A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults
Clinical trial NCT03768609 · COMPLETED
Trial details
- NCT number
- NCT03768609
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2019-03-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.